16th Feb 2006 16:40
FULL YEAR 2005 RESULTS DATE NOTIFICATION23 February 2006Basingstoke, UK and Philadelphia, US - 16 February 2006 - Shire plc (LSE: SHP,NASDAQ: SHPGY, TSX: SHQ) will announce full year 2005 earnings on Thursday 23February 2006.Results press release will be issued at: 12:00 GMT / 07:00 ET Investor conference call time: 14:00 GMT / 09:00 ET Live analyst presentation and conference call:Matthew Emmens, Chief Executive Officer and Angus Russell, Chief FinancialOfficer will host the investor and analyst meeting and live conference call at14:00 GMT/9:00 ET. The venue for the meeting will be at the offices ofFinancial Dynamics Offices, Holborn Gate, 26 Southampton Buildings, London WC2A1PBPlease RSVP [email protected] for the live presentation.Live conference call:The details of the live conference call are as follows:UK dial in +44 (0) 1452 568 061 US / Canada dial in 1 866 224 2914 International dial in + 44 (0)1452 569 103 Password/Conf ID 5601288 Please RSVP [email protected] for the conference callLive Webcast:The call will also be available live over the Internet via audio webcast,accessible through www.shire.com in the investor relations section. A slidepresentation to accompany the call will also be available on the Shire website.Replay:A replay of the presentation will be available for two weeks. Details are asfollows:UK dial in 0845 245 5205 International dial in +44(0) 1452 55 00 00 Pin code 5595703# Webcast replay www.shire.com, in the investor relations section If you have any problems accessing this, please contact: Souheil Salah on: +44(0) 1256 894160For further information please contact:Investor Relations Souheil Salah (Rest of the World) +44 1256 894 160 Heidi Wunder (North America) +1 484 595 8970 Notes to editorsSHIRE PLCShire's strategic goal is to become the leading specialty pharmaceuticalcompany that focuses on meeting the needs of the specialist physician. Shirefocuses its business on central nervous system (CNS), gastrointestinal (GI),general products (GP) and human genetic therapies (HGT) - all being areas inwhich Shire has a commercial presence. The structure is sufficiently flexibleto allow Shire to target new therapeutic areas to the extent opportunitiesarise through acquisitions. Shire believes that a carefully selected portfolioof products with a strategically aligned and relatively small-scale sales forcewill deliver strong results. Shire's focused strategy is to develop and marketproducts for specialty physicians. This approach aims to deliver increasedreturns and lower risks. Shire's in-licensing and merger and acquisitionefforts are focused on products in niche markets with strong intellectualproperty protection either in the US or Europe.For further information on Shire, please visit the Company's website: www.shire.com.Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com Press Release Registered in England 2883758 Registered Office as aboveENDSHIRE PLCRelated Shares:
Shire